Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method
2023 · BMC Cancer · 6 citations
https://doi.org/10.1186/s12885-023-11121-9
G
Ghanshyam Biswas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
193
Citations
8
h-index
5
i10-index
Ghanshyam Biswas is an academic researcher from Institute of Medical Sciences and Sum Hospital. The author has contributed to research in topics: Chronic Myeloid Leukemia Treatments & Lymphoma Diagnosis and Treatment & HER2/EGFR in Cancer Research. The author has an h-index of 8, co-authored 32 publications.
Papers by this author
worksExPert ConsEnsus on the management of Advanced clear-cell RenaL celL carcinoma: INDIAn Perspective (PEARL-INDIA)
2023 · BMC Cancer · 2 citations
https://doi.org/10.1186/s12885-023-11237-y
An Open-Label, Single-Arm, Multicenter, Observational Study Evaluating the Safety and Effectiveness of Akynzeo® in the Management of Chemotherapy-Induced Nausea and Vomiting in India
2024 · Cureus · 0 citations
https://doi.org/10.7759/cureus.c169
Real-World Experience With Panitumumab or Bevacizumab as a First-Line Treatment for Metastatic Colorectal Cancer: An Indian Perspective
2025 · Cureus · 0 citations
https://doi.org/10.7759/cureus.97914
Efficacy of Low-Dose Nivolumab in Advanced Carcinomas
2026 · Indian Journal of Medical and Paediatric Oncology · 0 citations
https://doi.org/10.1055/s-0046-1818401
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat